Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users

被引:65
作者
Carbone, J
Gil, J
Benito, JM
Navarro, J
Muñóz-Fernández, A
Bartolomé, J
Zabay, JM
López, F
Fernández-Cruz, E
机构
[1] Univ Complutense, Gen Hosp Gregorio Maranon, Dept Immunol, Madrid 28007, Spain
[2] Nufarm 21, Madrid, Spain
关键词
CD4+CD38+DR+ lymphocyte subset; CD4 lymphocyte counts; CD8 T cell subsets; disease progression; HIV; HIV RNA; immune activation; intravenous drug users; longitudinal cohort study; prognosis;
D O I
10.1097/00002030-200012220-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To identify subsets of CD4 T lymphocytes that can predict the development of AIDS and to assess whether increased levels of these cellular markers could provide additional independent prognostic information to the CD4 T cell count and plasma HIV-1-RNA levels. Design and methods: In a prospective study, a cohort of 85 HIV-positive intravenous drug users [clinical categories of the CDC classification A (n = 48) and B (n = 37)] were followed for a period of 37 +/- 13 months. Memory and activated CD4 and CD8 T cells were quantitated by three-colour flow cytometry at baseline and expressed as a percentage of total CD4 and CD8 lymphocytes. Clinical evaluations were performed at 6 month intervals. The relationships between these lymphocyte subsets and progression to AIDS were studied using Kaplan-Meier plots and proportional hazards regression models. Results: After adjustment for the level of CD4 T cells and plasma HIV-1-RNA levels, the elevation in the subset CD4+CD38+DR+ was the marker within the functionally distinct subsets of CD4 T lymphocytes with additional prognostic value in bivariate Cox regression models. In multivariate models, increased percentages of CD4+CD38+DR+ T cells provided the strongest independent prognostic information for progression to AIDS (relative hazard, 1.07; P < 0.0001). Conclusion: Our results suggest that high levels of CD4+CD38+HLA-DR+ T cells reflect the increasing degree of CD4 T cell activation during the progression of HIV infection, and could be used together with the CD4 T cell and HIV-RNA levels to evaluate more accurately the progressive cellular immune impairment associated with the risk of progression to AIDS. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:2823 / 2829
页数:7
相关论文
共 42 条
  • [1] IMMUNE CHANGES IN HIV-1 INFECTION - SIGNIFICANT CORRELATIONS AND DIFFERENCES IN SERUM MARKERS AND LYMPHOID PHENOTYPIC ANTIGENS
    BASS, HZ
    NISHANIAN, P
    HARDY, WD
    MITSUYASU, RT
    ESMAIL, E
    CUMBERLAND, W
    FAHEY, JL
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (01): : 63 - 70
  • [2] Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: Changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens
    Benito, JM
    Zabay, JM
    Gil, J
    Bermejo, M
    Escudero, A
    Sanchez, E
    FernandezCruz, E
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (02): : 128 - 135
  • [3] Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients
    Bofill, M
    Mocroft, A
    Lipman, M
    Medina, E
    Borthwick, NJ
    Sabin, CA
    Timms, A
    Winter, M
    Baptista, L
    Johnson, MA
    Lee, CA
    Phillips, AN
    Janossy, G
    [J]. AIDS, 1996, 10 (08) : 827 - 834
  • [5] Centers for Disease Control, 1992, MMWR-MORBID MORTAL W, V41, pRR
  • [6] Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements
    Fahey, JL
    Taylor, JMG
    Manna, B
    Nishanian, P
    Aziz, N
    Giorgi, JV
    Detels, R
    [J]. AIDS, 1998, 12 (13) : 1581 - 1590
  • [7] THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    FAHEY, JL
    TAYLOR, JMG
    DETELS, R
    HOFMANN, B
    MELMED, R
    NISHANIAN, P
    GIORGI, JV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) : 166 - 172
  • [8] IMMUNOLOGICAL AND SEROLOGICAL MARKERS PREDICTIVE OF PROGRESSION TO AIDS IN A COHORT OF HIV-INFECTED DRUG-USERS
    FERNANDEZCRUZ, E
    DESCO, M
    MONTES, MG
    LONGO, N
    GONZALEZ, B
    ZABAY, JM
    [J]. AIDS, 1990, 4 (10) : 987 - 994
  • [9] Activated naive and memory CD4+ and CD8+ subsets in different stages of HIV infection
    Ginaldi, L
    DeMartinis, M
    DOstilio, A
    DiGennaro, A
    Marini, L
    Profeta, V
    Quaglino, D
    [J]. PATHOBIOLOGY, 1997, 65 (02) : 91 - 99
  • [10] Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection
    Giorgi, JV
    Majchrowicz, MA
    Johnson, TD
    Hultin, P
    Matud, J
    Detels, R
    [J]. AIDS, 1998, 12 (14) : 1833 - 1844